- Home
- SVRN vs AIDX Comparison
SVRN vs AIDX Comparison
Compare SVRN & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRN | AIDX |
|---|---|---|
| Founded | 2021 | N/A |
| Country | Greece | United States |
| Employees | 87 | N/A |
| Industry | Marine Transportation | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 19.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRN | AIDX |
|---|---|---|
| Price | $10.95 | $1.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.5M | 112.8K |
| Earning Date | 04-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.51 |
| 52 Week High | $12.39 | $14.09 |
Technical Indicators
Market Signals| Indicator | SVRN | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 86.25 | 17.07 |
| Support Level | $0.51 | $1.51 |
| Resistance Level | N/A | $2.08 |
| Average True Range (ATR) | 1.27 | 0.20 |
| MACD | 0.76 | 0.25 |
| Stochastic Oscillator | 89.78 | 61.40 |
Price Performance
Historical ComparisonAbout SVRN OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary. The company includes Dry Bulk segment and Tanker segment. Majority of revenue is Dry Bulk segment.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.